Eric mann - Health Technology Forum - final 2013-06-26

Copyright © 2013, Oracle and/or its affiliates. All rights reserved.1
Eric Mann
Director, Product Marketing
Oracle Health Sciences
eric.mann@oracle.com
@ericmannsf
Healthcare in the Cloud

The following is intended to outline our general product
direction. It is intended for information purposes only, and may
not be incorporated into any contract. It is not a commitment to
deliver any material, code, or functionality, and should not be
relied upon in making purchasing decisions.
The development, release, and timing of any features or
functionality described for Oracle’s products remains at the
sole discretion of Oracle.
Safe Harbor Statement

CLINICAL
INNOVATION
REGULATION COMPETITION
CARE
DELIVERY
ECONOMIC
PERSONALIZED
Forces Transforming
Healthcare
Source: Paul Keckley, Ph.D., “Health Reform Memo”, Deloitte CFO Journal, Wall Street Journal, April 29, 2013

“It is far more important
to know what person
the disease has
than to know what disease
the person has.”
− Hippocrates
c. 460−370 B.C.

Getting Personal Matters

PREVENT
MANAGE
IMPROVE
LOWER
Individuals & Populations

“We are now building
a national highway system
for personalized medicine.
We look forward to
navigating these roads
to better outcomes
and better health.”
− Margaret A. Hamburg, M.D. and
Francis S. Collins, M..D., Ph.D.,
New England Journal of Medicine
July 22, 2010
13
prominent examples of
personalized medicine drugs,
treatments and diagnostics
products available in 20061
72
prominent examples of
personalized medicine drugs,
treatments and diagnostics
products available in 20112
1,2,3: Isaac S. Chan and Geoffrey S. Ginsburg “Personalized Medicine: Progress and
Promise” Annual Review of Genomics and Human Genetics, Sept. 2011, Vol. 12:217-244

Progress in Personalized Medicine
Healthcare
2008
4%
2009
22%
2010
50%
U.S. population with
medical information in
some form of electronic
health records3
U.S. hospitals with fully operational
electronic health records1,2
Life Sciences
30%
Biopharmaceutical
companies that
require compounds
to have biomarker1
50%
Clinical trials that
collect patient DNA
to aid in biomarker
development2
75%
Increase in
personalized
medicine investment
over last 5 years3
1,2,3: Isaac S. Chan and Geoffrey S. Ginsburg “Personalized Medicine: Progress and
Promise” Annual Review of Genomics and Human Genetics, Sept. 2011, Vol. 12:217-244

Silos Stifle Insight & Collaboration
Electronic
Health
Records
Diet, Lifestyle
& Exercise
Regulatory
Data
Genetics
Omics Data Environment
Payer

Personalized Healthcare Requires a 360° View of the Individual
Genetics
Omics Data
Diet, Lifestyle
& Exercise
Electronic
Health
Records Environment
Therapy
Adherence

Cloud Enables Mechanics of
Personalization

Cloud Empowers
Researchers
§  Accelerate the pace of converting scientific discoveries into
clinical advances
§  Relieve researchers from funding cycle pressures
§  Provide centralized support for IT, molecular platforms,
bioinformatics, clinical trial lifecycle mgmt

Cloud Empowers
Providers
Moffit’s Total Cancer Care
integrates data with a common
cancer care protocol for 90,000
patients at 17 institutions across
10 states

Cloud Empowers
Life Sciences
CAL
The Clinical Aggregation Layer
§  Unified, single version of truth for cleaning,
transformation, and analysis
§  Open architecture to support the right analysis
and visualization tool for job
§  Scalable to support very large data volumes
§  Extensible for enterprise application
integration

Cloud Empowers
Regulators Press Release: Medicines regulator implements innovative software to
analyse risk data and target inspection activity
As part of its risk-based inspections regime which ensures compliance with statutory
obligations relating to medicines the Medicines and Healthcare products Regulatory
Agency (MHRA) is implementing new IT software.
MHRA inspections across all the disciplines will be better prioritised as a result, helping to
target its activity to the areas of greatest risk and ultimately help protect public health.
This risk-based approach helps reduce the overall administrative and economic burden on
companies and organisations operating in the public health arena who are regulated by
MHRA and who demonstrate a high level of compliance.
Gerald Heddell, the MHRA’s Director of Inspections, Enforcement and Standards, said:
“It’s vital we move with the times and this new software will help collate all the information
we need in one location to make informed risk-based decisions on those we inspect and
improve our capability to ensure the quality of medicines used in the UK. Our inspectorate
teams will focus their time on inspections in order of priority from the risk signals flagged.”
“MHRA, through its inspection processes and programs, plays an essential role in
safeguarding public health. The ability to apply resources to the areas of greatest potential
risk is vital to optimizing the agency’s resources and impact,” said Neil de Crescenzo,
senior vice president and general manager, Oracle Health Sciences. “We are delighted to
work with MHRA on this innovative initiative.”

Cloud Empowers
Individuals
Participatory Medicine
§  Knowledge availability
§  Records / information access
§  Tools
§  Community

The Right Cloud for the Job
Public Hybrid Private

Clouds Break
Down Barriers to
Personalized Medicine
TODAY
•  Unconnected, unaligned
ecosystem
•  Silos of data
•  Limited information and insights
TOMORROW
•  Seamlessly connected ecosystem
•  End-to-end, secure data
management platform
•  Insights across the ecosystem
Pulling Together

Healthcare in the Cloud

Eric mann - Health Technology Forum - final 2013-06-26

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Eric mann - Health Technology Forum - final 2013-06-26

Similar to Eric mann - Health Technology Forum - final 2013-06-26 (20)

Recently uploaded

Recently uploaded (20)

Eric mann - Health Technology Forum - final 2013-06-26